Significant differences in LGR5 levels were observed between high-grade (WHO III and IV) and low-grade (WHO I and II) glioma as well as between WHO I and WHO II glioma (P < 0.001, P < 0.05, respectively, Fig. 6b). This evidence concerns the gene LGR5 and glioma.